30/Jan/2024
A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway
DOI: 10.31744/einstein_journal/2024RW0552
ABSTRACT Introduction Triple-negative breast cancer is an aggressive subtype of breast cancer characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression. This phenotype renders triple-negative breast cancer cells refractory to conventional therapies, resulting in poor clinical outcomes and an urgent need for novel therapeutic approaches. Recent studies have implicated dysregulation of the Notch receptor signaling pathway in the development and progression of triple-negative breast cancer. Objective This study aimed to conduct a […]
Keywords: Cell proliferation; MicroRNAs; Molecular targeted therapy; Notch1; Receptors; Signal transduction; Triple-negative breast neoplasms
10/Nov/2023
Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review
DOI: 10.31744/einstein_journal/2023RW0387
ABSTRACT Introduction The increasing popularity of cannabinoids for treating numerous neurological disorders has been reported in various countries. Although it reduces tetrahydrocannabinol psychoactivity, it helps patients tolerate higher doses and complements the anti-spasmodic effects of tetrahydrocannabinol. One of the most important potential of cannabinoids are related to its potential to help children with cerebral palsy, a contributor of lifelong disability. Therefore, this systematic review aimed to assess the efficacy and safety of medical cannabinoids in children with cerebral palsy. Methods […]
Keywords: Cannabinoids; Cerebral palsy; Child; Efficacy; Patient safety; Safety
31/Jul/2023
The effects of gratitude interventions: a systematic review and meta-analysis
DOI: 10.31744/einstein_journal/2023RW0371
ABSTRACT Introduction Gratitude has several implications. Over time, a logical relationship has been established between gratitude and well-being. In addition, researchers aimed to establish associations between gratitude and other factors of positive feelings using scientific methods. We conducted a systematic review and meta-analysis of interventions to develop gratitude and its benefits to human beings. Objective This study aimed to evaluate and quantify the available scientific evidence on interventions to acquire knowledge on gratitude as a quantifiable causal factor of benefit […]
Keywords: Anxiety; Delivery of health care; Depression; Emotions; Gratitude; Health facilities; Mental Health; Narration; Personnel satisfaction
05/Jul/2023
Effects of neurofeedback on major depressive disorder: a systematic review
DOI: 10.31744/einstein_journal/2023RW0253
ABSTRACT Background Major depressive disorder is a difficult-to-treat psychological disorder. Approximately 30% of patients with major depressive disorder do not respond to conventional therapies; thus, the efficacy of alternative therapies for treating major depressive disorder, such as neurofeedback, a non-invasive neuromodulation method used in the treatment of psychiatric diseases, must be investigated. Objective We aimed to evaluate the efficacy of neurofeedback in minimizing and treating major depressive disorder and its application as a substitute to or an adjuvant with conventional […]
Keywords: Brain waves; Depressive disorder, major; Neurofeedback
06/Jun/2023
Effects of statin therapy in hospitalized adult COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
einstein (São Paulo). 06/Jun/2023;21:eRW0351.
View Article06/Jun/2023
Effects of statin therapy in hospitalized adult COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
DOI: 10.31744/einstein_journal/2023RW0351
ABSTRACT Introduction COVID-19 is associated with endothelial activation and systemic inflammation; consequently, statins can be used in its treatment as they have anti-inflammatory, antithrombotic, and profibrinolytic properties and may interfere with COVID-19 viral entry into cells through disruption of cell membrane lipid rafts. Objective We performed a meta-analysis of randomized clinical trials that compared statin therapy to placebo or to standard care in adult patients hospitalized for COVID-19. Methods We searched the MEDLINE, EMBASE, and Cochrane Library databases for all-cause […]
Keywords: Atorvastatin; Coronavirus infections; COVID-19; Hydroxymethylglutaryl-CoA reductase inhibitors; SARS-CoV-2
06/Jun/2023
HIV and neoplasms: What do we know so far?
DOI: 10.31744/einstein_journal/2023RW0231
ABSTRACT Introduction The human immunodeficiency virus (HIV) pandemic remains an important issue. In 2020, approximately 37.7 million people were living with the disease and there were more than 680 thousand deaths due to complications linked to the disease. Despite these exorbitant numbers, the introduction of highly active antiretroviral therapy has marked a new era, changing the epidemiological profile of the infection and related pathologies, including neoplasms. Objective We performed a literature review to assess the role of neoplasms in patients […]
Keywords: Acquired immunodeficiency syndrome; Antiretroviral therapy, highly active; Carcinogenesis; HIV; Neoplasms
21/Nov/2022
Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
DOI: 10.31744/einstein_journal/2022RW0045
ABSTRACT Objective We performed a systematic review of the literature and meta-analysis on the efficacy and safety of hydroxychloroquine to treat COVID-19 patients. Methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and LILACS (January 2019 to March 2021) for patients aged 18 years or older, who had COVID-19 and were treated with hydroxychloroquine versus placebo or standard of care. We also searched the WHO Clinical Trials Registry for ongoing and recently completed studies, and the […]
Keywords: Coronavirus infections; COVID-19; Disease prevention; Drug-related side effects and adverse reactions; Hydroxychloroquine; SARS-CoV-2; Therapeutics
21/Nov/2022
Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
einstein (São Paulo). 21/Nov/2022;20:eRW0015.
View Article21/Nov/2022
Antibiotic prophylaxis in pregnant with premature rupture of ovular membranes: systematic review and meta-analysis
DOI: 10.31744/einstein_journal/2022RW0015
ABSTRACT Objective To perform a systematic review and meta-analysis of randomized clinical trials that compared the use of antibiotics versus placebo in premature rupture of membranes preterm and evaluated maternal, fetal and neonatal outcomes in pregnant women with premature rupture of ovular membranes at a gestational age between 24 and 37 weeks. Methods A search was conducted using keywords in PubMed, Cochrane, Biblioteca Virtual em Saúde and Biblioteca Digital de Teses e Dissertações da USP between August 2018 and December […]
Keywords: Anti-bacterial agents; Antibiotic prophylaxis; Fetal membranes; Gestational age; Infant; Pregnant Women; Premature; premature rupture
09/Nov/2022
Hypothesis on ontogenesis and pathophysiology of Alzheimer’s disease
DOI: 10.31744/einstein_journal/2022RW0170
ABSTRACT Alzheimer’s disease is a neurodegenerative condition that causes changes in memory and cognition, in addition to behavioral disorders, and most commonly affects the elderly. Several studies in the literature have presented therapeutic measures in an attempt to interfere with the pathogenic mechanisms of the disease and to mitigate its clinical manifestations. Some factors, such as excitotoxicity, cholinergic dysfunctions, oxidative stress, tau protein hyperphosphorylation, changes in amyloid-beta peptide metabolism, herpes viruses, apolipoprotein E, glycogen synthase kinase 3, insulin resistance, and […]
Keywords: Alzheimer disease; Amyloid beta-peptides; Apolipoprotein E4; Cyclic AMP response element-binding protein; Diabetes mellitus type 3; Endocannabinoids; Glycogen synthase kinase 3; Insulin resistance; Oxidative stress; Tau proteins
13/Oct/2022
International trends in pulmonary neuroendocrine cancer studies:a scientometric study
DOI: 10.31744/einstein_journal/2022RW0113
ABSTRACT Introduction Pulmonary neuroendocrine tumors account for approximately 20% of all primary lung tumors. Few studies summarize the current body of pulmonary neuroendocrine tumors studies worldwide. Objective A quantitative scientometric analysis was conducted to evaluate the development of applications and innovations and to analyze their contribution to various areas of improvement in treatment and diagnosis of pulmonary neuroendocrine tumors. Methods We searched for studies published in the last 20 years in the databases United States National Library of Medicine (PubMed), […]
Keywords: Lung neoplasms; Neuroendocrine tumors; Scienciometry; Scientometric analysis